| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $482.4M | +20.0% |
| Cost of Revenue | $6.5M | +20.4% |
| R&D Expense | $184.4M | +40.7% |
| SG&A Expense | $184.3M | +20.6% |
| Operating Income | $107.3M | -4.8% |
| Pre-tax Income | $124.6M | +7.2% |
| Income Tax | $18.4M | +24.7% |
| Net Income | $106.1M | +4.7% |
| EPS (Basic) | $1.02 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $135.6M | +104.4% |
| Short-term Investments | $232.7M | -36.3% |
| Accounts Receivable | $41.1M | +32.4% |
| Inventory | $7.7M | +26.7% |
| Current Assets | $458.6M | -8.1% |
| Total Assets | $621.5M | +6.5% |
| Current Liabilities | $104.5M | +44.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $127.0M | +5.6% |
| Capital Expenditures | $139K | -66.3% |
| Investing Cash Flow | $90.9M | +179.5% |
| Financing Cash Flow | -$148.7M | -760.5% |
| Free Cash Flow | $126.9M | +5.8% |
| +7.4% |
| EPS (Diluted) | $0.94 | +8.0% |
| Total Liabilities |
| $114.8M |
| +40.7% |
| Stockholders' Equity | $506.7M | +1.0% |